Healthcare
fromBusiness Insider
1 week agoHealthcare company Ensemble Health has tapped JP Morgan as it eyes a $13 billion sale or IPO in 2026
Ensemble Health is pursuing a dual-track sale or IPO targeting a roughly $13 billion valuation with JPMorgan and Goldman Sachs involved.